glp-1 after bariatric surgery Vs. GLP-1: Which Weight Loss Option Fits You? Physiological effects of crucial hormones

Proponents of GLP-1 microdosing claim the mini doses help promote weight management after weight loss, but Barenbaum remains skeptical

Chronic pancreatitis, in which symptoms do not improve or keep reoccurring, is most commonly caused by alcohol abuse

In this episode, a rheumatologist who has been researching the drugs for rheumatoid arthritis discusses what we know so far about their potential uses in arthritis and what is still being investigated

As technologies like AI-powered triage and remote monitoring evolve, the role of telehealth in chronic disease management will only expand

Appetite regulation is orchestrated by a complex network of physical and chemical signals, with enteroendocrine hormones serving as some of the most powerful drivers of hunger and satiety

What Clinicians Should Expect Next May 11, 2026 Articles, Diabetes, GLP- 1 Agonist Therapy Center, GLP-1 Agonist Therapy Center, Obesity, Obesity, Therapies, Type 2 Diabetes, Type 2 Diabetes 1,313 views The rapid rise of GLP-1 receptor agonists has transformed diabetes treatment and obesity management over the past decade